Suchergebnisse - "Halpin, David M G"

PubPharm (191)

11

Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma

enthalten in: ERJ open research | 2023

von Corren, J. | Katelaris, C. | Castro, M. | +10

12

Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards : an observational longitudinal study

enthalten in: The Lancet regional health. Europe | 2023

von Halpin, D. | Dickens, A. | Skinner, D. | +22

13

A Response to : Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis"

enthalten in: Advances in therapy | 2023

von Ismaila, A. | Haeussler, K. | Malmenäs, M. | +5

CommentOn: Adv Ther. 2022 Sep;39(9):3957-3978. - PMID 35849317

14

A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”

enthalten in: Advances in therapy | 2023

von Ismaila, A. | Haeussler, K. | Malmenäs, M. | +5

15

A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”

enthalten in: Advances in therapy | 2023

von Ismaila, A. | Haeussler, K. | Malmenäs, M. | +5

16

A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”

enthalten in: Advances in therapy | 2023

von Ismaila, A. | Haeussler, K. | Malmenäs, M. | +5

17

Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD : Post Hoc Analysis of the IMPACT Trial

enthalten in: Chronic obstructive pulmonary diseases (Miami, Fla.) | 2023

von Wells, J. | Criner, G. | Halpin, D. | +8

18

Clinical Management of COPD in the Real World : Can Studies Reveal Errors in Management and Pathways to Improve Patient Care?

enthalten in: Pragmatic and observational research | 2023

von Halpin, D.

19

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease : Post hoc analysis of the IMPACT trial

enthalten in: Respirology (Carlton, Vic.) | 2022

von Thompson, P. | Criner, G. | Dransfield, M. | +9

CommentIn: Respirology. 2022 Dec;27(12):1006-1007. - PMID 36031687

20

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD : IMPACT trial post hoc analysis

enthalten in: Respiratory medicine | 2022

von Bardsley, S. | Criner, G. | Halpin, D. | +12